2-42264719-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_019063.5(EML4):āc.655A>Gā(p.Ile219Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000617 in 1,297,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_019063.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EML4 | NM_019063.5 | c.655A>G | p.Ile219Val | missense_variant | 6/23 | ENST00000318522.10 | NP_061936.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EML4 | ENST00000318522.10 | c.655A>G | p.Ile219Val | missense_variant | 6/23 | 1 | NM_019063.5 | ENSP00000320663 | P3 | |
EML4 | ENST00000402711.6 | c.481A>G | p.Ile161Val | missense_variant | 5/22 | 1 | ENSP00000385059 | |||
EML4 | ENST00000401738.3 | c.655A>G | p.Ile219Val | missense_variant | 6/24 | 5 | ENSP00000384939 | A1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000890 AC: 2AN: 224748Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 122290
GnomAD4 exome AF: 0.00000617 AC: 8AN: 1297268Hom.: 0 Cov.: 24 AF XY: 0.00000460 AC XY: 3AN XY: 651970
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The c.655A>G (p.I219V) alteration is located in exon 6 (coding exon 6) of the EML4 gene. This alteration results from a A to G substitution at nucleotide position 655, causing the isoleucine (I) at amino acid position 219 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at